More than 200 researchers studying 224 tumors may have found a genetic vulnerability in colon cancer that could lead to targeted treatments, according to a paper published in the journal Nature. Scientists plan to test drugs already approved for other cancers that share the genetic aberration. The research is part of the Cancer Genome Atlas project, funded by the National Cancer Institute and the National Human Genome Research Institute.
Cancer Genome Atlas project yields possible breakthrough
SmartBrief Job Listings for Health Care